BDNF and Huntington disease: Although most recent studies consistently report a decrease in BDNF levels in Huntington’s disease animal models and patients, the varying results warrant further study on the potential use of peripheral BDNF levels and BDNF-promoter methylation as biomarkers of Huntington’s disease onset and psychiatric symptoms.